These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 11354255)
1. Molecular link between cholesterol, cytokines and atherosclerosis. Kaul D Mol Cell Biochem; 2001 Mar; 219(1-2):65-71. PubMed ID: 11354255 [TBL] [Abstract][Full Text] [Related]
2. Is there a genetic basis for resistance to atherosclerosis? Stein O; Thiery J; Stein Y Atherosclerosis; 2002 Jan; 160(1):1-10. PubMed ID: 11755917 [TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450--physiological key factor against cholesterol accumulation and the atherosclerotic vascular process. Luoma PV Ann Med; 2007; 39(5):359-70. PubMed ID: 17701478 [TBL] [Abstract][Full Text] [Related]
4. EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein E-deficient mice from developing atherosclerotic lesions. Marleau S; Harb D; Bujold K; Avallone R; Iken K; Wang Y; Demers A; Sirois MG; Febbraio M; Silverstein RL; Tremblay A; Ong H FASEB J; 2005 Nov; 19(13):1869-71. PubMed ID: 16123174 [TBL] [Abstract][Full Text] [Related]
5. Downregulated CD36 and oxLDL uptake and stimulated ABCA1/G1 and cholesterol efflux as anti-atherosclerotic mechanisms of interleukin-10. Rubic T; Lorenz RL Cardiovasc Res; 2006 Feb; 69(2):527-35. PubMed ID: 16336952 [TBL] [Abstract][Full Text] [Related]
6. Liver X receptor stimulates cholesterol efflux and inhibits expression of proinflammatory mediators in human airway smooth muscle cells. Delvecchio CJ; Bilan P; Radford K; Stephen J; Trigatti BL; Cox G; Parameswaran K; Capone JP Mol Endocrinol; 2007 Jun; 21(6):1324-34. PubMed ID: 17405904 [TBL] [Abstract][Full Text] [Related]
7. Liver X receptor signaling pathways in cardiovascular disease. Tontonoz P; Mangelsdorf DJ Mol Endocrinol; 2003 Jun; 17(6):985-93. PubMed ID: 12690094 [TBL] [Abstract][Full Text] [Related]
8. Effect of macrophage overexpression of murine liver X receptor-alpha (LXR-alpha) on atherosclerosis in LDL-receptor deficient mice. Teupser D; Kretzschmar D; Tennert C; Burkhardt R; Wilfert W; Fengler D; Naumann R; Sippel AE; Thiery J Arterioscler Thromb Vasc Biol; 2008 Nov; 28(11):2009-15. PubMed ID: 18787185 [TBL] [Abstract][Full Text] [Related]
9. SREBP-2 positively regulates transcription of the cholesterol efflux gene, ABCA1, by generating oxysterol ligands for LXR. Wong J; Quinn CM; Brown AJ Biochem J; 2006 Dec; 400(3):485-91. PubMed ID: 16901265 [TBL] [Abstract][Full Text] [Related]
15. Liver X receptors and the control of cholesterol homeostasis: potential therapeutic targets for the treatment of atherosclerosis. Millatt LJ; Bocher V; Fruchart JC; Staels B Biochim Biophys Acta; 2003 Mar; 1631(2):107-18. PubMed ID: 12633677 [TBL] [Abstract][Full Text] [Related]
16. Oxysterol signaling links cholesterol metabolism and inflammation via the liver X receptor in macrophages. Töröcsik D; Szanto A; Nagy L Mol Aspects Med; 2009 Jun; 30(3):134-52. PubMed ID: 19248804 [TBL] [Abstract][Full Text] [Related]
17. Induction of transglutaminase 2 by a liver X receptor/retinoic acid receptor alpha pathway increases the clearance of apoptotic cells by human macrophages. Rébé C; Raveneau M; Chevriaux A; Lakomy D; Sberna AL; Costa A; Bessède G; Athias A; Steinmetz E; Lobaccaro JM; Alves G; Menicacci A; Vachenc S; Solary E; Gambert P; Masson D Circ Res; 2009 Aug; 105(4):393-401. PubMed ID: 19628791 [TBL] [Abstract][Full Text] [Related]
18. LXR (liver X receptor) and HNF-4 (hepatocyte nuclear factor-4): key regulators in reverse cholesterol transport. Crestani M; De Fabiani E; Caruso D; Mitro N; Gilardi F; Vigil Chacon AB; Patelli R; Godio C; Galli G Biochem Soc Trans; 2004 Feb; 32(Pt 1):92-6. PubMed ID: 14748721 [TBL] [Abstract][Full Text] [Related]
19. C-reactive protein induces pro- and anti-inflammatory effects, including activation of the liver X receptor alpha, on human monocytes. Hanriot D; Bello G; Ropars A; Seguin-Devaux C; Poitevin G; Grosjean S; Latger-Cannard V; Devaux Y; Zannad F; Regnault V; Lacolley P; Mertes PM; Hess K; Longrois D Thromb Haemost; 2008 Mar; 99(3):558-69. PubMed ID: 18327405 [TBL] [Abstract][Full Text] [Related]
20. Identification of macrophage liver X receptors as inhibitors of atherosclerosis. Tangirala RK; Bischoff ED; Joseph SB; Wagner BL; Walczak R; Laffitte BA; Daige CL; Thomas D; Heyman RA; Mangelsdorf DJ; Wang X; Lusis AJ; Tontonoz P; Schulman IG Proc Natl Acad Sci U S A; 2002 Sep; 99(18):11896-901. PubMed ID: 12193651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]